FATE FATE THERAPEUTICS INCcompanySEC Filings & Insider Trading Activity 2026
Latest FATE THERAPEUTICS INC (FATE) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on November 13, 2025, an 8-K current report filed on February 26, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for FATE THERAPEUTICS INC (FATE) (SEC CIK 1434316), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 financial results released Feb 26, 2026
- • Specific figures (revenue, earnings, cash position) contained in Exhibit 99.1 press release
Recent 8-K FilingsCurrent Reports
AI-powered analysis of FATE THERAPEUTICS INC (FATE) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Feb 26, 2026 | — | Analysis | — |
10-K | Feb 26, 2026 | Dec 31, 2025 | — | |
10-Q | Nov 13, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 12, 2025 | Jun 30, 2025 | — | |
10-Q | May 13, 2025 | Mar 31, 2025 | — | |
10-K | Mar 5, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 13, 2024 | Jun 30, 2024 | — | |
10-Q | May 9, 2024 | Mar 31, 2024 | — | |
10-K | Feb 26, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 8, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 8, 2023 | Jun 30, 2023 | — | |
10-Q | May 3, 2023 | Mar 31, 2023 | — | |
10-K | Feb 28, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 3, 2022 | Jun 30, 2022 | — | |
10-Q | May 4, 2022 | Mar 31, 2022 | — | |
10-K | Feb 28, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 4, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 4, 2021 | Jun 30, 2021 | — | |
10-Q | May 5, 2021 | Mar 31, 2021 | — | |
10-K | Feb 24, 2021 | Dec 31, 2020 | — | |
10-Q | Nov 5, 2020 | Sep 30, 2020 | — | |
10-Q | Aug 5, 2020 | Jun 30, 2020 | — | |
10-Q | May 11, 2020 | Mar 31, 2020 | — |
Frequently Asked Questions
What are the latest FATE SEC filings in 2026?
FATE THERAPEUTICS INC (FATE) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 13, 2025, an 8-K current report on February 26, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did FATE file its most recent 10-K annual report?
FATE THERAPEUTICS INC (FATE) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view FATE 10-Q quarterly reports?
FATE THERAPEUTICS INC (FATE)'s most recent 10-Q quarterly report was filed on November 13, 2025. SignalX displays every FATE 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has FATE filed recently?
FATE THERAPEUTICS INC (FATE)'s most recent 8-K was filed on February 26, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find FATE insider trading activity (Form 4)?
SignalX aggregates every FATE Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does FATE file with the SEC?
FATE THERAPEUTICS INC (FATE) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new FATE filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for FATE THERAPEUTICS INC (FATE).
What is FATE's SEC CIK number?
FATE THERAPEUTICS INC (FATE)'s SEC CIK (Central Index Key) number is 1434316. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1434316 to look up all FATE filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find FATE return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from FATE THERAPEUTICS INC (FATE) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of FATE THERAPEUTICS INC SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 51+ filings.